LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that its Chief Executive Officer, Dr. Kevin Rodan, is expected to receive a Certificate of Excellence from the Ministry of Health. The recognition, scheduled to be presented on July 10, 2026, acknowledges Dr. Rodan's contributions to healthcare innovation, technological development, clinical practice, and healthcare advancement.
According to information provided to the Company, the certificate will be awarded as part of Ministry of Health initiatives focused on recognizing healthcare professionals whose work supports innovation, medical technology development, and high standards of patient care. The Company believes this recognition underscores the growing importance of healthcare technology, digital infrastructure, and innovation-focused leadership in modernizing healthcare systems throughout Latin America.
Dr. Kevin Rodan stated: "I am honored to be recognized in connection with healthcare innovation and excellence. Healthcare systems throughout Latin America continue to face significant accessibility, coordination, and infrastructure challenges, and I believe technology can play an important role in helping address those challenges. This recognition is meaningful not only personally, but also because it reflects the broader importance of innovation, collaboration, and patient-focused healthcare development."
The Certificate of Excellence is expected to be presented during an upcoming Ministry of Health event dedicated to recognizing contributions to healthcare advancement, innovation, and excellence within the healthcare sector. The Company noted that the recognition relates to Dr. Rodan's professional contributions and leadership and does not constitute a regulatory approval, endorsement, or certification of any specific product, service, technology, or commercial initiative of the Company.
This recognition highlights the increasing emphasis on digital health solutions in emerging markets, particularly in Latin America, where LataMed AI focuses its efforts. The Company's strategy centers on developing technology platforms for telehealth infrastructure, healthcare coordination, analytics, and AI-enabled solutions to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, payment solutions, and data-driven operations.
For additional information, visit https://latamed.ai or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
